Daxor Stock
Daxor Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- Michael Richard Feldschuh
- Employees
- 37
- Market cap
- $59 M
- IPO
- 25/07/1983
Based in Oak Ridge, Tennessee, Daxor Corporation is a healthcare company specializing in the development of medical technologies. Founded in 1971, the organization operates on the NASDAQ and operated under the name Idant Corporation prior to May 1973. The company's primary focus within the Medical - Instruments &…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Daxor stock: price history
1D
-1.5%
1W
-3.5%
1M
-14.2%
6M
+0.4%
YTD
-31.9%
1Y
-22.7%
2Y
+11.7%
5Y
-10.7%
10Y
+23.4%
Next earnings date
Next earnings date
10/03/2027 (in 144 days)
Volatility around earnings
~59% stronger price swings than usual
Ask the agents about Daxor
Analyst assessment of Daxor
PRICE TARGET LOW
US$23.00
CONSENSUS
US$23.00
MEDIAN
US$23.00
PRICE TARGET HIGH
US$23.00
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 17/03/2025
Daxor stock metrics
P/E
8.17
P/B
0.97
EV/EBITDA
9.42
RETURN ON EQUITY
-6.4%
NET MARGIN
-14,382.9%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
43.0%
FLOAT SHARES
2,509,581
AVG. DAILY VOLUME (30D)
33,366
Insider transactions (SEC)
Jefferies John
Feldschuh Jonathan Adam
Feldschuh Michael Richard
Michel Robert J
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about Daxor stock
What does Daxor do?
Daxor Corporation is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Michael Richard Feldschuh, the company employs around 37 people.
The IPO was on 25/07/1983; the stock trades on NASDAQ under the ticker DXR.
What do analysts say about Daxor stock?
3 analysts rate the stock, the consensus is Buy (as of 17/03/2025).
The average price target is US$23.00, ranging from US$23.00 to US$23.00, with a median of US$23.00.
This is an external assessment, not a statement by Market Jury.
When does Daxor report next?
The next earnings date is 10/03/2027.
Around past earnings, price swings were roughly 59% stronger than usual.
Does Daxor pay a dividend?
Yes. The last dividend was US$0.03 per share, ex-date 05/01/2018, paid on 12/01/2018.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to Daxor?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
How can I get Daxor stock analyzed?
Clicking "Analyze stock" lets five strategies assess Daxor against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.